Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia

Bulletin of the World Health Organization

Volumn 77, Issue 12, 1999, Pages 965-972

  Vardas, E ^a,b   Sitas, F ^a   Seidel, K ^c   Casteling, A ^a   Sim, J ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c Namibian Blood Transfusion Service   (Namibia)

Author keywords

Blood donors; Enzyme linked immunosorbent assay; Hepatitis C antibodies, diagnosis; Namibia; Polymerase chain reaction

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

DISEASE PREVALENCE; HEPATITIS;

ADOLESCENT; ADULT; AGE; ANALYTICAL EQUIPMENT; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING TEST; SEROPREVALENCE;

AFRICA; AFRICA SOUTH OF THE SAHARA; BLOOD DONORS; BLOOD SUPPLY; DEVELOPING COUNTRIES; DISEASES; ENGLISH SPEAKING AFRICA; EQUIPMENT AND SUPPLIES; EXAMINATIONS AND DIAGNOSES; HEPATITIS; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; MEASUREMENT; NAMIBIA; PREVALENCE; RESEARCH METHODOLOGY; RESEARCH REPORT; SOUTHERN AFRICA; VIRAL DISEASES;

ADOLESCENT; ADULT; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HUMANS; MALE; NAMIBIA; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES;

NAMIBIA;

EID: 0033373860     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hepatitis C: global prevalence. Weekly epidemiological record, 1997, 72 (46): 341-344.
2. Choo Q-L et al. Isolation of a cDNA clone derived from a non-A, non-B hepatitis genome. Science, 1989, 244: 359-362.
3. Kuo G et al. An assay for circulating antibodies to a major etiological virus of human non-A, non-B hepatitis. Science, 1989, 244: 362-364.
4. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes and cofactors. Epidemiological reviews, 1996, 18 (2): 137.
5. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Annals of internal medicine, 1996, 125: 658-668.
6. Tanaka K et al. Hepatitis C and B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer research, 1991, 51: 2842-2847.
7. Hopf U et al. Long-term follow up of post-transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus antibodies (HCV). Journal of hepatology, 1990, 10: 69-76.
8. Bruix J et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet, 1989, 2: 1004-1006.
9. Choo Q-L et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proceedings of the National Academy of Sciences of the USA, 1994, 91: 1294-1298.
10. Hepatitis C. Weekly epidemiological record, 1997, 72(10): 65-72.
11. Lavanchy D. The threat to public health of hepatitis C. Research in virology, 1997, 148: 143-145.
12. Van der Poel CL, Cuypers HT, Reesnik HW. Hepatitis C virus six years on. Lancet, 1994, 344: 1475-1479.
13. Tucker TJ et al. Hepatitis C virus infection in volunteer blood donors from the Western Cape - comparison of screening tests and PCR. South African medical journal, 1997, 87: 603-605.
14. Ellis LA et al. Prevalence of hepatitis C virus in South Africa: detection of anti-HCV in recent and stored serum. Journal of medical virology, 1990, 32: 249-251.
15. Abdool Karim SS, Tait DR. Hepatitis C virus infection in urban and rural Natal/Kwazulu. South African medical journal, 1993, 83: 191-193.
16. Seidel K et al. The prevalence of serological markers for hepatitis B amongst first-time blood donors in Namibia -Baseline studies for immunisation. Namibian Blood Transfusion Service and Department of Community Health, University of the Witwatersrand, 1997 (unpublished document).
17. Botha JF et al. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal transmission. Lancet, 1984, 1: 1210.
18. Cancer deaths 1996-1997. Namibian Cancer Registry, unpublished data, 1996, 1997.
19. Tsukuma H et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England journal of medicine, 1993, 328: 1797-1801.
20. Chuang WL et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. Cancer, 1992, 69: 2052-2054.
21. Garson JA et al. Enhanced detection by PCR of hepatitis C virus RNA. Lancet, 1990, 336: 878-879.
22. Quan CM et al. High-performance liquid chromatography to assess the effect of serum storage conditions on the detection of hepatitis C virus by the polymerase chain reaction. Journal of virological methods, 1993, 43: 299-307.
23. Okamoto H et al. Detection of hepatitis C virus RNA by a twostage polymerase chain reaction with two pairs of primers. Journal of virological methods, 1990, 43: 299.
24. Widell A et al. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C virus antibody assays. Journal of medical virology, 1991, 23: 458-462.
25. Davidson F et al. Variation in the hepatitis C virus 5′ non-coding region: implications for secondary structure. Journal of general virology, 1995, 67: 498-504.
26. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnosis. London, Churchill Livingstone, 1991.
27. Saito I et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the USA, 1990, 87: 6547-6549.
28. Shih CM et al. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH7 cells. Journal of virology, 1993, 67: 5823-5832.
29. Mutimer DJ et al. Hepatitis C virus infection in the asymptomatic British blood donor. Journal of viral hepatitis, 1995, 2: 47-53.
30. Courouce AM et al. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet, 1994, 343: 853-854.
31. Busch MP et al. Re-instatement of donors who test false-positive in second-generation hepatitis C virus enzyme immunoassays should wait availability of licensed third-generation tests. Transfusion, 1994, 34: 130-134.
32. Garcia Z et al. Evaluation of a pooling system for routine HCV screening of blood donors to lower the cost burden on blood banks in countries under development. Journal of medical virology, 1996, 49: 218-222.
33. Fong TL et al. Clinical significance of hepatitis C viral RNA and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests. Journal of medical virology, 1996, 49: 253-258.
34. Kolho E et al. Clinical significance of hepatitis C antibodies in blood donors. Journal of medical virology, 1994, 43: 129-134.
35. Caporaso N et al. HCV infection in symptom-free patients. Research in virology, 1997, 148: 123-125.
36. Oni AO, Harrison TJ. Genotypes of hepatitis C virus in Nigeria. Journal of medical virology, 1996, 49: 178-186.
37. Smuts H, Kannemeyer J. Genotyping of hepatitis C virus in South Africa. Journal of clinical microbiology, 1995, 33: 1679-1681.
38. Sithebe NP, Aspinall S, Smuts H. Molecular epidemiology of hepatitis C at Ga-Rankuwa Hospital. South African medical journal, 1996, 12: 1543-1545.
39. Bird AR, Gibbs BJ. Blood transfusion and hepatitis viruses. South African medical journal, 1994, 8: 570-572.
40. Donahue JG et al. The declining risk of post-transfusion hepatitis C virus infection. New England journal of medicine, 1992, 327: 369-372.